Skip to content

Serotonin research published in 2025

Page 8 of 8: studies 141 to 151 of 151, newest first. Back to the serotonin overview

Studies

In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor

Book of Proceedings 2025 Marina D. Kostić, Jana Nedić, Jovana S. Dragojević et al.

Serotonin receptors, also known as 5-hydroxytryptamine (5-HT) receptors, are a diverse family of G protein-coupled and ligand-gated ion channel receptors that mediate the physiological effects of the neurotransmitter serotonin. These receptors are widely distributed throughout the central and peripheral nervous systems, where they regulate numerous processes including mood, cognition,...

Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT 1A Receptor for Therapeutic Potential in Depression and Anxiety

Research 2025 Shujie Li, Shu-Jie Li, Qingning Yuan et al.

The 5-HT 1A receptor is a critical target in the treatment of depression and anxiety. Bufotenine derivatives, such as 5-methoxy- N , N -dimethyltryptamine (5-MeO-DMT), 5-hydroxy- N , N -dimethyltryptamine (5-OH-DMT), and 5-hydroxy- N , N , N -dimethyltryptamine—derived from traditional Chinese medicine—have shown antidepressant potential. However, the structural basis of their interaction with...

The Effect of Psilocybin on Cortical Neural Dynamics, Sleep-Wake Behavior, and Persistent Pain in a Rat Model

University of Michigan Library 2025 Nicholas Kolbman

Psilocybin containing mushrooms have been utilized for ceremonial, medicinal, and spiritual purposes for millennia. Recently there has been a surge of scientific interest in the therapeutic potential and mechanistic understanding of serotonergic psychedelics, including psilocybin. Psilocybin is classified as a serotonergic psychedelic because the non-ordinary state of consciousness that it...

Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them - A scoping review of available literature.

Brain Research 2025 Leonor Miranda 59 citations

Psychedelic drugs that activate the 5HT2A receptor have long been the target of extensive clinical research, particularly in models of psychiatric illness. The aim of this literature review was to investigate the therapeutic effects of 5HT2A receptor activation in the anterior cingulate cortex (ACC) and the respective mechanisms that underlie them. Based on the available research, I suggest...

Serotonin, immune function, and psychedelics as potent anti-inflammatories.

International review of neurobiology 2025 Charles D. Nichols, Timothy P. Foster 4 citations

Psychedelics are primarily recognized for their profound behavioral effects, leading most research on psychedelics and their primary target, the 5-HT2A receptor, to focus on brain activity. However, these receptors are not only found within the brain and are present in nearly every tissue and cell type throughout the body, playing a significant role alongside serotonin in modulating various...

DOI: 10.1016/bs.irn.2025.04.011 (opens in new tab) Full text (opens in new tab) Immune system Psychedelic therapy psychedelics Therapeutic potential New strategy +8

Serotonergic psychedelics for depression: A comprehensive overview.

International review of neurobiology 2025 A M Wingert, Claudio Agnorelli, Joseph Peill et al. 1 citation

Depressive disorders continue to pose a major clinical challenge worldwide, particularly given the high prevalence and increasing number of treatment-resistant cases. Over the past decade, advances in research have elucidated the antidepressant potential of psilocybin and other 5-HT₂A receptor agonists in patients with major depressive disorder (MDD) and treatment-resistant depression (TRD)....

The protective effect of DMT against neurodegeneration.

International review of neurobiology 2025 Ede Frecska, Attila Kovács, Attila Szabo 2 citations

This paper explores the therapeutic potential of DMT in neuroprotective strategies, particularly concerning ischemia-reperfusion injury (IRI) and neurodegenerative disorders. Besides its potent serotonin receptor actions, DMT is also an endogenous agonist of the sigma-1 receptor (Sig-1R). Sigma receptors are a unique family of proteins with high expression in the brain and spinal cord and have...

DOI: 10.1016/bs.irn.2025.04.010 (opens in new tab) Full text (opens in new tab) Serotonin DMT Alzheimer’s disease Amyotrophic lateral sclerosis +8

Potential Serotonin 5-HT2A Receptor Agonist of Psychoactive Components of Silene undulata Aiton: LC-MS/MS, ADMET, and Molecular Docking Studies.

Current Pharmaceutical Biotechnology 2025 Maram B Alhawarri, Suleiman Olimat 10 citations

Silene undulata is historically used for inducing vivid and prophetic lucid dreams, but limited information exists on its phytochemical composition and potential pharmacological properties. This study aimed to investigate the phytochemical composition of S. undulata through LC-MS/MS analysis and explore its potential serotonergic activity, which could support and confirm the traditional use of...

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice.

Molecular Psychiatry 2025 Margareth Nogueira, Daiane C Ferreira Golbert, Richardson Menezes et al. 18 citations

Serotonergic psychedelics have potential therapeutic effects in treating anxiety and mood disorders, often after a single dose, and are suggested to have plasticity-inducing action. However, a comprehensive mechanism of action is still lacking. Here, we investigated how a single dose of the short-acting 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) acts on gene expression from microdissected...

DOI: 10.1038/s41380-024-02655-w (opens in new tab) Full text (opens in new tab) Psychopharmacology Anxiety research Natural compounds

Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

Cureus 2025 Sorcha O'Connor, Kate Godfrey, Sara Reed et al. correction

Background: Obsessive-compulsive disorder (OCD) is a complex condition marked by persistent distressing thoughts and repetitive behaviours. Despite its prevalence, the mechanisms behind OCD remain elusive, and current treatments are limited. This protocol outlines an investigative study for individuals with OCD, exploring the potential of psilocybin to improve key components of cognition...

DOI: 10.7759/cureus.c209 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Clinical research OCD

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Neuroscience of Consciousness 2025 Christopher Timmermann, James W. Sanders, David Reydellet et al. 19 citations

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews,...

DOI: 10.1093/nc/niaf007 (opens in new tab) Full text (opens in new tab) Serotonin EEG Neurophenomenology Consciousness-research +3